SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-001930
Filing Date
2024-01-10
Accepted
2024-01-10 15:21:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 1095665
2 annex-a_001.jpg GRAPHIC 2329
  Complete submission text file 0001493152-24-001930.txt   1100034
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41534 | Film No.: 24526381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)